Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Trips, CBD and Traditional Medicines: Concepts and Questions. Report of an ASEAN Workshop on the TRIPS Agreement and Traditional Medicine, Jakarta, February 2001
(2001; 88 pages)
Table of Contents
View the documentACKNOWLEDGEMENTS
View the documentLIST OF ABBREVIATIONS AND ACRONYMS
View the documentLIST OF RESOURCE PERSONS
View the documentEXECUTIVE SUMMARY
View the documentI. INTRODUCTION
Open this folder and view contentsII. CONTEXT
Open this folder and view contentsIII. KEY INTERNATIONAL AGREEMENTS
Open this folder and view contentsIV. IPR & TRADITIONAL MEDICINE: MISMATCH
Open this folder and view contentsV. CONCEPTS, OBJECTIVES AND CONFLICTS
Open this folder and view contentsVI. OPTIONS AND CHOICES
Open this folder and view contentsVII. POLICIES AND STRATEGIES
Open this folder and view contentsVIII. EXAMPLES
View the documentWORKSHOP RECOMMENDATIONS
View the documentANNEX A - Workshop Agenda
View the documentANNEX B - Opening Remarks
View the documentANNEX C - Selected Articles of the Convention on Biological Diversity
View the documentANNEX D - List of Participants
 

WORKSHOP RECOMMENDATIONS

Recommendations from the Delegates to the ASEAN workshop
on the TRIPS Agreement and traditional medicine
Jakarta, 15 February 2001

In order to achieve the principal objective of safeguarding people's access to traditional medicines to cover their health needs, as well as the additional objectives of:

» Ensuring equitable benefit sharing in case of commercial use of Traditional Medicine,

» Protecting against the use of Traditional Medicinal Knowledge (TMK) and Traditional Medicine (TM) without authorization from the holders of such TMK/TM,

» Creating incentives for continued development of Traditional Medicinal Knowledge and Traditional Medicine,

» Supporting the development of the (traditional medicine) industry,

» Supporting measures to protect the environment and avoid over-exploitation,

ASEAN Member Countries reiterate the recommendations from the ASEAN Workshop on the TRIPS Agreement and its Impact on Pharmaceuticals (Jakarta, 2-4 May 2000), and recommend the following basic strategies:

1. Developing a National Traditional Medicine Policy, in order to, among others:

» Address the formal recognition of Traditional Medicine,

» Strengthen the organization and infrastructure of Traditional Medicine (including quality and safety aspects),

» Explore the integration of Traditional Medicine in the National Health Care System (e.g. inclusion in curriculum),

» Increase funds for research and development on Traditional Medicines.

2. Developing national legislation in order to implement TRIPS and CBD, and notably to:

» Develop creative approaches to protect Traditional Medicinal Knowledge and Traditional Medicine, such as sui generis systems, new IPR regulations or the appropriate use of the existing IPR mechanism,

» Explore the possibility of requiring submission of: (i) a certificate of origin and (ii) a certified statement that any knowledge and/or materials have been obtained with the prior informed consent of their holders, for any application of a patent based on or making use of TMK, TM, biological materials and/or genetic resources,

» Accelerate the implementation of the Convention on Biological Diversity (CBD) and/or its guiding principles, notably those relating to: (i) sovereignty over genetic resources and (ii) the protection of the knowledge, innovations, practices and customs of local and indigenous communities in the area of traditional medicine,

» Develop national and regional mechanisms for the prevention of biopiracy.

3. Taking a firm position and playing an active role during the review of the TRIPS Agreement in the WTO TRIPS Council, noting that:

» Any revision of TRIPS Article 27.3(b) should exclude the patentability of plants and animals;

» Specific, concrete steps should be taken, in order to develop a detailed ASEAN position on TRIPS, for example by conducting preparatory meetings prior to the actual WTO TRIPS review (involving technical experts on health, traditional medicine and IPR),

Moreover, the workshop identified the need to:

» Conduct a comprehensive study on the real and potential impact of the TRIPS Agreement on the use and protection of TMK/TM, taking into account studies that have already been conducted,

» Conduct a study of all TRIPS provisions (including those pertaining to geographical indications, trademarks, etc) and their potential application in the area of TKM/TM.

4. Establishing an information network

» by appointing a national coordinator for the exchange of information on traditional medicines among ASEAN countries,

» by creating national and regional networks for information exchange,

» in order to, among others, document knowledge of traditional medicine which is already in the public domain, in various written forms, and distribute it widely to interested stakeholders, including healers and IPR offices. Modern technology could be used, for example by developing a Traditional Knowledge Digital Library.

5. Reinforcing technical cooperation among Member Countries, among others by:

» Strengthening the existing activities on herbal medicines within the ASEAN TCDC in Pharmaceuticals,

» Enlarging the scope of ASEAN TCDC, in order to include the priorities identified in this Workshop with regard to the protection of Traditional Medicine, such as the implementation of systems for the protection of TMK/TM and the development of Traditional Medicine data bases55,

55 If these databases are public, they should only contain knowledge which is already in the public domain.

» Exploring the possibility for harmonization of minimum regulatory standards and requirements for traditional medicines on the aspects of acceptable quality, safety and efficacy.

6. Trying, at the international level, to spearhead efforts for the promotion and protection of traditional medicines and traditional medicinal knowledge, and notably to:

» Develop and introduce a Resolution to this end in the World Health Assembly, which should address IPR issues as well as quality, safety, efficacy and proper use of traditional medicines; the part of the Resolution addressing the protection of TMK/TM should be developed in collaboration with WIPO and representatives from relevant CBD Working Groups,

» Adopt a protocol/amendment to the Convention on Biological Diversity, devising specific solutions for the legal protection for TMK/TM and the participation of the communities concerned in making decisions regarding the development and use of their resources and knowledge,

» Introduce international, legally binding instruments, which will protect TKM/TM,

» Identify, at the international, ASEAN as well as national level, criteria for the protection of TMK/TM.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014